Key result
A 39-year-old male with severe Streptococcus mitis endocarditis and cardiogenic shock was successfully treated with mitral valve replacement under venoarterial extracorporeal membrane oxygenation support.
Case Report (n=1)
Highlights the use of VA-ECMO as hemodynamic support for high-risk mitral valve replacement in a patient with cardiogenic shock secondary to severe endocarditis.
No takes yet. Share an insight, caveat, or question.
Right-sided S. mitis endocarditis can occur in non-IVDU children; leaves open pediatric-specific valve predilection and risk stratification.
Ahmed et al. (2020) conducted a case report in Severe Streptococcus Mitis Endocarditis (n=1). Mitral valve replacement under venoarterial extracorporeal membrane oxygenation (VA-ECMO) support was evaluated on Clinical recovery. A 39-year-old male with severe Streptococcus mitis endocarditis and cardiogenic shock was successfully treated with mitral valve replacement under venoarterial extracorporeal membrane oxygenation support.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: